Clinical Trial Update: Acceptability of a Fixed Combination of Fenofibrate and Metformin [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating the acceptability of a fixed-dose combination of fenofibrate and metformin for dyslipidemia and disorders of glucose met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Glucose Metabolism
• Dyslipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• metformin (metformin)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Dyslipidemia/Glucose Metabolism Disorder | Phase 3 | Status: COMPLETED